Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Researchers discover a new neurodegenerative disease known as Vacuolar Tauopathy

Staff Writer
Staff Writer 3 years ago
Updated 2020/10/01 at 11:43 PM
Share
SHARE

A newly discovered disease by a team of researchers at the University of Pennsylvania School of Medicine shines a new spotlight on a form of protein build up in the brain associated with the development of neurodegenerative diseases like Alzheimer’s disease.

The new research, released in the journal Science, involved the examination of brain tissue samples from a deceased participant with an undefined neurodegenerative disease and an animal model.

When examining the participant’s samples, the Penn Medicine team uncovered a mutation in the valosin-containing protein (VCP) gene, leading to the discovery of what they now refer to as Vacuolar Tauopathy.

“Neurodegeneration in Alzheimer’s disease is closely associated with accumulation of pathologic tau aggregates in the form of neurofibrillary tangles,” the Penn Medicine research team stated in their journal article.

“What we found in this study is a pattern we’ve never seen before, together with a mutation that’s never been described before,” Edward Lee, one of the co-authors, stated in a news release.

According to the Penn Medicine team, the mutation may impair the proteins’ ability to break aggregates apart, a process strongly linked to dementia.

“Given that this mutation inhibits VCP activity, that suggest the converse might be true — that if you’re able to boost VCP activity, that could help break up the protein aggregates,” Lee explained.

“And if that’s true, we may be able to break up tau aggregates not only for this extremely rare disease, but for Alzheimer’s disease and other diseases associated with tau protein aggregation.”

Photo: Wikimedia

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

TAGGED: Vacuolar Tauopathy, Alzheimer's disease, dementia
Staff Writer October 1, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Drinking morning coffee after breakfast improves metabolic control
Next Article Yoga and mindfulness could be beneficial for reducing chronic pain

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?